68.80
-1.10
(-1.57%)
At close: 12:07:52 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-61,236.00
-65,545.00
-63,603.00
-61,708.00
-92,158.00
Investing Cash Flow
-124,818.00
-307,202.00
-164,986.00
-23,802.00
-57,118.00
Financing Cash Flow
178,242.00
339,006.00
151,375.00
-5,655.00
145,441.00
End Cash Position
8,981.00
19,898.00
53,639.00
130,853.00
222,018.00
Capital Expenditure
-7,439.00
-15,983.00
-14,607.00
-23,994.00
-56,849.00
Issuance of Capital Stock
184,199.00
344,877.00
159,044.00
3,691.00
155,253.00
Free Cash Flow
-68,675.00
-81,528.00
-78,210.00
-85,702.00
-149,007.00
12/31/2020 - 5/13/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6662.TWO BioLASCO Taiwan Co., Ltd.
33.00
-0.30%
6949.TW Pell Bio-Med Technology Co., Ltd.
80.00
0.00%
6461.TWO Intech Biopharm Corporation
24.85
+0.20%
6709.TWO Advagene Biopharma Co., Ltd.
20.25
+0.25%
6986.TWO HeXun Biosciences Co., Ltd.
71.80
+1.84%
6850.TWO BiOptic Inc.
41.15
+1.11%
6973.TWO U-Neuron Biomedical Inc
38.60
+0.65%
6917.TWO Andros Pharmaceuticals Co.,Ltd
18.20
+0.55%
7754.TWO AnnJi
32.55
-3.70%
4131.TWO NeoCore Technology Co., Ltd.
31.00
0.00%